Team:MIT/Medals
From 2014.igem.org
(Difference between revisions)
Line 23: | Line 23: | ||
<dt><b>iGEM projects involve important questions beyond the bench, for example relating to (but not limited to) ethics, sustainability, social justice, safety, security, or intellectual property rights. Describe an approach that your team used to address at least one of these questions. Evaluate your approach, including whether it allowed you to answer your question(s), how it influenced the team’s scientific project, and how it might be adapted for others to use (within and beyond iGEM). We encourage thoughtful and creative approaches, and those that draw on past Policy & Practice (formerly Human Practices) activities.</b></dt> | <dt><b>iGEM projects involve important questions beyond the bench, for example relating to (but not limited to) ethics, sustainability, social justice, safety, security, or intellectual property rights. Describe an approach that your team used to address at least one of these questions. Evaluate your approach, including whether it allowed you to answer your question(s), how it influenced the team’s scientific project, and how it might be adapted for others to use (within and beyond iGEM). We encourage thoughtful and creative approaches, and those that draw on past Policy & Practice (formerly Human Practices) activities.</b></dt> | ||
<dd><i>Q: How will we deliver our system into the human body?</i> | <dd><i>Q: How will we deliver our system into the human body?</i> | ||
- | <br>A: As mentioned before, we contacted various professionals and they helped guide our decisions with their opinions and insights into the current state of Alzheimer’s research. However, our project is ultimately one that must be generally acceptable to its users (and the public as a whole) for it to serve its purpose. | + | <br>A: As mentioned before, we contacted various professionals and they helped guide our decisions with their opinions and insights into the current state of Alzheimer’s research. However, our project is ultimately one that must be generally acceptable to its users (and the public as a whole) for it to serve its purpose. |
- | <br>We were contemplating several possible delivery strategies, each of which had its own technical pros and cons. However, what we sorely lacked was the point of view of the general public - how would an Alzheimer’s patient feel about receiving our therapeutics? In what manner would he/she prefer to be treated? | + | <br> We were contemplating several possible delivery strategies, each of which had its own technical pros and cons. However, what we sorely lacked was the point of view of the general public - how would an Alzheimer’s patient feel about receiving our therapeutics? In what manner would he/she prefer to be treated? |
- | <br>To address this, we designed a public opinion survey, which aimed to determine what method of delivery would cause the least public outcry and be able to be administered as a therapeutic to the largest majority of people. | + | <br> To address this, we designed a public opinion survey, which aimed to determine what method of delivery would cause the least public outcry and be able to be administered as a therapeutic to the largest majority of people. |
The survey data was useful and provided results akin to those we expected. In general, people are more comfortable with less invasive methods of delivery. This lead to design decisions for our project that are compatible with viral delivery to neurons, that would be (theoretically) administered via blood injection. | The survey data was useful and provided results akin to those we expected. In general, people are more comfortable with less invasive methods of delivery. This lead to design decisions for our project that are compatible with viral delivery to neurons, that would be (theoretically) administered via blood injection. | ||
- | <br>This survey could be easily modified and used for any project considering the public opinion of their research/science. It includes several set-up and gating questions, and is short, simple and quick. More details about our survey may be found here: [link to survey page].</dd></dl></li> | + | <br> This survey could be easily modified and used for any project considering the public opinion of their research/science. It includes several set-up and gating questions, and is short, simple and quick. More details about our survey may be found here: [link to survey page].</dd></dl></li> |
</ol> | </ol> | ||
</tr></td> | </tr></td> | ||
Line 49: | Line 49: | ||
<dt><b>iGEM projects involve important questions beyond the bench, for example relating to (but not limited to) ethics, sustainability, social justice, safety, security, or intellectual property rights. Articulate at least one question encountered by your team, and describe how your team considered the(se) question(s) within your project. Include attributions to all experts and stakeholders consulted.</b></dt> | <dt><b>iGEM projects involve important questions beyond the bench, for example relating to (but not limited to) ethics, sustainability, social justice, safety, security, or intellectual property rights. Articulate at least one question encountered by your team, and describe how your team considered the(se) question(s) within your project. Include attributions to all experts and stakeholders consulted.</b></dt> | ||
<dd><i>Q: How will we deliver our system into the human body?</i> | <dd><i>Q: How will we deliver our system into the human body?</i> | ||
- | <br> A: This question arose at the beginning of our research journey, and continued to affect the direction of our project over the subsequent months. As a potential therapy for Alzheimer’s disease, our system would have to somehow be inserted into the human body. We considered several aspects of this process, and though we would never be performing it ourselves, we sought to design our system such that the safest, most effective and publicly acceptable method of delivery may be used. | + | <br> A: This question arose at the beginning of our research journey, and continued to affect the direction of our project over the subsequent months. As a potential therapy for Alzheimer’s disease, our system would have to somehow be inserted into the human body. We considered several aspects of this process, and though we would never be performing it ourselves, we sought to design our system such that the safest, most effective and publicly acceptable method of delivery may be used. |
- | We began by interviewing professionals in the field of neuroscience and Alzheimer’s disease (see our Outreach page for more details [link to Outreach]). Armed with the industry opinion and our own research, we developed (in theory) various methods of delivery and considered pros and cons of each. | + | <br> We began by interviewing professionals in the field of neuroscience and Alzheimer’s disease (see our Outreach page for more details [link to Outreach]). Armed with the industry opinion and our own research, we developed (in theory) various methods of delivery and considered pros and cons of each. |
- | <br> We also considered the necessity of public approval of the system for it to be effective as a therapeutic. This led to the formulation of our public opinion survey, found here [link to Survey page]. | + | <br> We also considered the necessity of public approval of the system for it to be effective as a therapeutic. This led to the formulation of our public opinion survey, found here [link to Survey page]. |
- | Ultimately, these considerations aided us in designing the system that we have developed. We targeted the path of neuron delivery, but are conscious of the numerous other (and possibly better) delivery options that exist, which we had neither the time nor the resources to explore.</dd></dl></li> | + | <br> Ultimately, these considerations aided us in designing the system that we have developed. We targeted the path of neuron delivery, but are conscious of the numerous other (and possibly better) delivery options that exist, which we had neither the time nor the resources to explore.</dd></dl></li> |
</ol> | </ol> | ||
</p></tr></td> | </p></tr></td> | ||
Line 87: | Line 87: | ||
</td></tr> | </td></tr> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
<tr><td><br></tr></td> | <tr><td><br></tr></td> | ||
</table> | </table> | ||
</html> | </html> |
Revision as of 03:07, 17 October 2014
Home | Our Project | Lab Work | Outreach | About Us | Medals |
Medals | |
Gold Medal | |
| |
Silver Medal | |
| |
Bronze Medal | |
| |